BLADDER CANCER
 
Bladder cancer biomarkers and BCG
Recent study findings have implications for noninvasive markers to predict the course of urothelial cell carcinoma.
Learn more
ADVERTISEMENT
 
Untreated MIBC has short natural course, significant morbidity
"There appears to be a strikingly high likelihood of increased morbidity and poor outcomes in patient who are not receiving definitive therapy," writes Badar M. Mian, MD.
Read his column
 

 
 
MORE FROM UROLOGY TIMES
 
Metastatic bladder Ca: High ORR seen with immunotherapy combo
Gender disparities in bladder cancer management
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont